🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Prostate SBRT after TURP: feasible, but careful patient selection after multiple TURP and adenomectomy. Impact of post-surgical cavity resection volume? ⁦Vérane Achard⁩ ⁦Vedang Murthy⁩ sciencedirect.com/science/articl…

Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity ⁦Vérane Achard⁩ ⁦Vedang Murthy⁩ ⁦Priyamvada Maitre⁩ ctro.science/article/S2405-…

Prostate #SBRT after prior TURP? Useful points in this latest review led by Huck constance and Thomas Zilli in Clinical & Translational Radiation Oncology ESTRO ctro.science/article/S2405-…

DEBATE : 🇫🇷🇮🇳🇨🇦TMT is A standard of Care ⚡Inform patients, they need to see a radonc and a urologist and a medical oncologist 👉Work to do: How to define complete response after TMT? MRI for better local staging? 🌍No need to have underwears to come in @FOCUS_meeting 🙏Thanks

✨More than happy to have the Australian Goat Shankar Siva in #Bordeaux to talk about the last innovations in the management of GU tumors 💪 @BERGONIE33 CHU de Bordeaux

Addition of RT to the primary in mHSPC #PEACE1 For the low volume population: 🔴No OS benefit 🟢rPFS benefit for patients treated with abiraterone In the overall population: 🟢Reduction of the occurence of serious GU events thelancet.com/journals/lance…

✨Our systematic review focusing on TMT and concomitant Chemo regimen for patients with MIBC 👉 Heterogeneity ++ 👉Overall, similar OS and safety outcomes 👉Highest LOE=5FU-Mitomycin C 👉Data regarding elderly patients and QOL insufficiently reported sciencedirect.com/science/articl…

🌞Une superbe édition des RR 2024 avec un groupe dynamique d'oncologues, urologues et radiothérapeutes. 🌞Tout sur le cancer de la prostate dans un programme interactif🤝 👉On se retrouve pour la 3e en 2025 ! Pignot Géraldine Alberto Bossi @stephaneculine @jacquesirani Renard Penna

Shilpa Gupta Andrea Necchi Dr. Jason Efstathiou Toni Choueiri, MD Rana McKay, MD, FASCO Sumanta K. Pal, MD, FASCO Jonathan Rosenberg MD IBCG We have performed a review dedicated to this topic... Just submitted. 🙏 With Huck constance Vérane Achard Evanguelos Xylinas Morgan Roupret tombal Dr. Jason Efstathiou Julien Van Damme Prof Ananya💙 @achoud72.bsky.social ✨Trial to come... 🤞 Vérane Achard

📢 STORM trial breaking results at #ESTRO25! 🧪 MDT vs ENRT+MDT for nodal oligorecurrent PCa. 🧬 ENRT+MDT: ✅ Superior bRFS (57% vs 41%, p=0.014) ✅ Superior pelvic control (lrRFS 85% vs 62%, p=0.006) ✅ Superior MFS (76% vs 63%, p=0.06) ❌ No increase in ≥G2 GU/GI toxicity

EAU Guidelines Update: European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines by Antoine G. van der Heijden et al Read the full update here: buff.ly/DFOK4dt #UroSoMe #MedTwitter #EurUrol

New insights on SBRT in recurrent ovarian cancer – now in CTRO: “SBRT in recurrent oligometastatic ovarian cancer: An EORTC Y-ECI GCG systematic review” 👉 doi.org/10.1016/j.ctro… 🎯 Local control ⏳ Delayed systemic therapy ⚖️ Personalized strategy EORTC

📢This might just be THE DEFINITIVE meta-analysis of PSMA PET for #prostatecancer recurrence. 🚨Meta-analysis of 43 studies (n=8,119) ⬆️Sensitivity from 48% at PSA 0.2–0.5 ng/ml to >90% at PSA >2. Congrats Declan Murphy marlon perera + team European Association of Urology (EAU)! ➡️link shorturl.at/unfn5

How to manage gynecomastia with ARPIs monotherapy? A review by @nassimVibert 🙏 sciencedirect.com/science/articl… #ProstateCancer #Prostate #life

🚨 MUST READ 🚨 🔥 Bladder preservation with CIS? Time to rethink the rules. 👉 New in EUO: sciencedirect.com/science/articl… 🙏 Grateful to the amazing team! #BladderCancer #Urology #RadiationTherapy #BladderPreservation #CIS